FDA issues Guidance for a clear Identification of pharmaceutical Companies
Recommendation

10-12 November 2026
Hamburg, Germany
An advanced Auditor Course with many interactive Sessions and practical Examples
In our GMP News from September 2013 you learned about a draft of a FDA Guidance for Industry entitled "Specification of the Unique Facility Identifier (UFI) System for Drug Establishment Registration". This document's goal was to clearly identify pharmaceutical sites. The draft comprised (manageable) five pages - including the cover page. And in terms of volume this didn't change. However, some of the alternatives still mentioned in the draft, are not stated any longer - as one can find out when contacting the authority in these cases. The method now wanted is a registration by a D-U-N-S- (Data Universal Numbering System) number. This number - which is a 9-digit code - is supplied by the company Dun & Bradstreet.
To find out more please see the complete Guidance for Industry "Specification of the Unique Facility Identifier (UFI) System for Drug Establishment Registration".
Related GMP News
02.11.2026Singapore Added to the List of Recognised third Countries for Importation of APIs
02.11.2026Failed GMP Training in 2026: Further GMP Training Deficiencies in FDA Warning Letters
21.10.2026Switzerland: GMP Compliance by Foreign Manufacturers
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management

